NADELLOSE SPRITZE

Patent europeic · EP3970769 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3970769
Numer da la dumonda
EP21764051
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
04-03-2021
Publitgà
23-03-2022
Concedì
25-06-2025
Stritgà
23-10-2026
Motiv
Taxa annuala betg pajada
Classas IPC
A61M 5/30 (2006.01)
A61M 37/00 (2006.01)
A61M 5/315 (2006.01)
A61M 5/20 (2006.01)
A61M 5/31 (2006.01)
Prioritad
KR 20200028431 06.03.2020
Dumonda PCT
PCT/KR2021/002692 04.03.2021
Publicaziun PCT
WO2021/177753 10.09.2021
Lingua da l’annunzia
corean
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-10-2026

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.10.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.10.2026

  2. 07-05-2026

    Midada

    Published in Swissreg on 07.05.2026

  3. 25-06-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 25.06.2025

Partidas

Possessur

Baz Biomedic Co., Ltd.

Seoul 06133, KR

Inventur

KIM, Jung Kook

Daejeon 34817, KR

LEE, Sung Hun

Gapyeong-gun Gyeonggi-do 12428, KR

HAM, Hwi Chan

Seoul 08789, KR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.